These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6313141)

  • 21. Valbenazine granted breakthrough drug status for treating tardive dyskinesia.
    Müller T
    Expert Opin Investig Drugs; 2015 Jun; 24(6):737-42. PubMed ID: 25809133
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management.
    Nasrallah HA; Dunner FJ; McCalley-Whitters M; Smith RE
    J Clin Psychiatry; 1986 Feb; 47(2):56-9. PubMed ID: 3003037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Identification and evaluation of properties of benzodiazepine receptors of glial and neuronal fractions of human cerebral cortex].
    Zlobina GP; Chekalina ND; Oifa AI; Mukhin AG
    Biull Eksp Biol Med; 1982 Oct; 94(10):51-4. PubMed ID: 6293610
    [No Abstract]   [Full Text] [Related]  

  • 24. Tardive dyskinesia presenting as gastrointestinal disorder.
    Goldberg RJ; Morris PL; Lidofsky S
    J Clin Psychiatry; 1990 Jun; 51(6):253-4. PubMed ID: 1971823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Central administration of the neurotensin receptor antagonist SR48692 attenuates vacuous chewing movements in a rodent model of tardive dyskinesia.
    McCormick SE; Stoessl AJ
    Neuroscience; 2003; 119(2):547-55. PubMed ID: 12770567
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycoprotein properties of benzodiazepine receptors from calf cerebral cortex.
    Sherman-Gold R; Dudai Y
    J Neurosci Res; 1983; 10(1):27-33. PubMed ID: 6310136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tardive dyskinesia: pathophysiology and animal models.
    Casey DE
    J Clin Psychiatry; 2000; 61 Suppl 4():5-9. PubMed ID: 10739324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Group-selective reagent modification of the benzodiazepine-gamma-aminobutyric acid receptor-ionophore complex reveals that low-affinity gamma-aminobutyric acid receptors stimulate benzodiazepine binding.
    Burch TP; Thyagarajan R; Ticku MK
    Mol Pharmacol; 1983 Jan; 23(1):52-9. PubMed ID: 6306426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anosognosia in tardive dyskinesia: "tardive dysmentia" or "tardive dementia"?
    Myslobodsky MS
    Schizophr Bull; 1986; 12(1):1-6. PubMed ID: 2870563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Physiopathology and curative treatment of tardive dyskinesia].
    Wolf MA; Gautier J
    Encephale; 1987; 13(5):301-8. PubMed ID: 2892663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroleptic-induced tardive dyskinesia.
    Jenner P; Marsden CD
    Acta Psychiatr Belg; 1987; 87(5):566-98. PubMed ID: 2897761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlorpromazine-induced neuroleptic malignant syndrome and its response to diazepam.
    Lew TY; Tollefson G
    Biol Psychiatry; 1983 Dec; 18(12):1441-6. PubMed ID: 6661471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diazepam in the treatment of extrapyramidal symptoms: a case report.
    Director KL; Muniz CE
    J Clin Psychiatry; 1982 Apr; 43(4):160-1. PubMed ID: 6121790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Midification of tardive dyskinesia and spasmodic torticollis by apomorphine. Possible role of dopamine autoreceptors.
    Tolosa ES
    Arch Neurol; 1978 Jul; 35(7):459-62. PubMed ID: 666598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose pyridoxine in tardive dyskinesia.
    DeVeaugh-Geiss J; Manion L
    J Clin Psychiatry; 1978 Jun; 39(6):573-5. PubMed ID: 350860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholinergic influences in tardive dyskinesia.
    Tamminga CA; Smith RC; Ericksen SE; Chang S; Davis JM
    Am J Psychiatry; 1977 Jul; 134(7):769-74. PubMed ID: 869054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
    Bai YM; Yu SC; Lin CC
    J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Case report of adverse effect of reserpine on tardive dyskinesia.
    Donatelli A; Geisen L; Feuer E
    Am J Psychiatry; 1983 Feb; 140(2):239-40. PubMed ID: 6129810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of tardive dyskinesia with bromocriptine. A test of the receptor modification strategy.
    Lieberman JA; Alvir J; Mukherjee S; Kane JM
    Arch Gen Psychiatry; 1989 Oct; 46(10):908-13. PubMed ID: 2572205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxiperomide in tardive dyskinesia.
    Casey DE; Gerlach J
    J Neurol Neurosurg Psychiatry; 1980 Mar; 43(3):264-7. PubMed ID: 7373324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.